| Yendamuri, Saikrishna |
Roswell Park Cancer Institute Corp
United States |
Metformin for chemoprevention of lung cancer in obese subjects at high risk |
3R01CA255515-04S1 |
Eva Szabo, M.D. |
| Yilmaz, Omer |
Massachusetts Institute Of Technology
United States |
PROSPECT - Stem cell models |
1OT2CA297570-01 |
Asad Umar, D.V.M., Ph.D. |
| You, Ming |
Methodist Hospital Research Institute
United States |
Chemoprevention of lung cancer by targeting lonidamine to mitochondria |
5R01CA232433-05 |
John Clifford, Ph.D. |
| You, Ming |
Methodist Hospital Research Institute
United States |
Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis |
5R01CA280746-02 |
John Clifford, Ph.D. |
| Young, Steven L |
Duke University
United States |
Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis |
5P01HD106485-04 |
Goli Samimi, Ph.D., M.P.H. |
| Yu, Danxia |
Vanderbilt University Medical Center
United States |
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery |
5R01CA275864-02 |
Edward Sauter, M.D., Ph.D. |
| Yu, Anthony Francis |
Sloan-Kettering Inst Can Research
United States |
Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial |
5R37CA273923-03 |
Eileen Dimond, R.N., M.S. |
| Yu, Anthony Francis |
Sloan-Kettering Inst Can Research
United States |
Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial |
5R37CA273923-03 |
Eileen Dimond, R.N., M.S. |
| Yu, Dihua |
University Of Tx Md Anderson Can Ctr
United States |
Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer |
5R01CA270010-03 |
Marjorie Perloff, M.D. |
| Zeng, Melody Yue |
Weill Medical Coll Of Cornell Univ
United States |
Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis |
5R21CA270998-02 |
Young Kim, Ph.D. |
| Zi, Xiaolin |
University Of California-Irvine
United States |
Nautral products for targeting Skp2 in cancer interception |
5UG3CA290368-02 |
Altaf Mohammed, Ph.D. |
